Related Experiment Videos
Working towards an NHS standard for aseptic non-touch technique
Stephen Rowley1, Susan Sinclair
1Haematology Unit, University College Hospital, London. stephen.rowley@uclh.org
Nursing Times
|March 19, 2004
Summary
Health care-associated infections (HCAI), including methicillin-resistant Staphylococcus aureus (MRSA), remain a significant challenge in the UK despite increased funding. Rising MRSA rates and associated costs highlight the urgent need for effective control strategies.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Public Health
Background:
- Health care-associated infections (HCAI) persist as a major challenge within healthcare systems.
- Methicillin-resistant Staphylococcus aureus (MRSA), a notable 'superbug', contributes significantly to the HCAI burden.
- The UK experiences a higher incidence rate of MRSA compared to other European nations.
Purpose of the Study:
- To highlight the ongoing problem of HCAI in the UK.
- To emphasize the rising incidence and impact of MRSA.
- To underscore the economic and mortality costs associated with hospital-acquired infections.
Main Methods:
- Analysis of national data on HCAI incidence.
- Review of MRSA prevalence rates in the UK and Europe.
- Examination of economic impact assessments and mortality statistics related to HCAI.
Main Results:
- Despite increased National Health Service (NHS) funding, HCAI remains a significant issue.
- MRSA incidence in the UK is increasing at a faster rate than in comparable European countries.
- Hospital-acquired infections incur an estimated annual cost of 1 billion Pounds and cause 5,000-15,000 deaths annually.
Conclusions:
- HCAI, particularly MRSA, represents a substantial and costly problem in UK healthcare.
- The rising trend of MRSA necessitates urgent attention and intervention strategies.
- Effective infection control measures are crucial to mitigate the economic and human cost of HCAI.